Literature DB >> 3037674

Animal models for acquired immunodeficiency syndrome.

R C Desrosiers, N L Letvin.   

Abstract

Substantial advances have already been made in the understanding of acquired immunodeficiency syndrome (AIDS). The major issues for AIDS research during the next few years must be practical ones: the development of a safe, effective vaccine for individuals not yet infected with the causative virus and the development of drug therapies for those already infected. Suitable animal models will be needed for studies designed to achieve these goals. Areas of investigation in animal models can be divided into four categories on the basis of increasing direct relevance to AIDS in humans: retroviruses that have no obvious, close relation to human immunodeficiency virus (HIV) but can induce chronic diseases with manifestations that include immunologic abnormalities; ungulate lentiviruses; HIV-related viruses of Old World primates; and HIV infection of chimpanzees. It is hoped that important research developments in experimental models can be quickly extrapolated to human AIDS.

Entities:  

Mesh:

Year:  1987        PMID: 3037674     DOI: 10.1093/clinids/9.3.438

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  16 in total

1.  New FDA drug approval policies and HIV vaccine development.

Authors:  W K Mariner
Journal:  Am J Public Health       Date:  1990-03       Impact factor: 9.308

2.  Magnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman Primates.

Authors:  Sheila M Keating; John W Heitman; Shiquan Wu; Xutao Deng; Andrea R Stacey; Roland C Zahn; Maurus de la Rosa; Samantha L Finstad; Jeffrey D Lifson; Michael Piatak; Marie-Claire Gauduin; Benedikt M Kessler; Nicola Ternette; Angela Carville; R Paul Johnson; Ronald C Desrosiers; Norman L Letvin; Persephone Borrow; Philip J Norris; Joern E Schmitz
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

3.  Cytokine enhancement of simian immunodeficiency virus (SIV/mac) from a chronically infected cloned T-cell line (HuT-78).

Authors:  M D Lairmore; A A Post; C S Goldsmith; T M Folks
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease.

Authors:  Marie-Chantal Simard; Pavel Chrobak; Denis G Kay; Zaher Hanna; Serge Jothy; Paul Jolicoeur
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Animal models for HIV infection and AIDS: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

6.  Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.

Authors:  Huma Qureshi; Zhong-Min Ma; Ying Huang; Gregory Hodge; Michael A Thomas; Janet DiPasquale; Veronique DeSilva; Linda Fritts; Andrew J Bett; Danilo R Casimiro; John W Shiver; Marjorie Robert-Guroff; Michael N Robertson; Michael B McChesney; Peter B Gilbert; Christopher J Miller
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 7.  Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primates.

Authors:  Joern E Schmitz; Birgit Korioth-Schmitz
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

8.  Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth.

Authors:  M Watanabe; D J Ringler; M Nakamura; P A DeLong; N L Letvin
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

9.  The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1.

Authors:  K Javaherian; A J Langlois; S Schmidt; M Kaufmann; N Cates; J P Langedijk; R H Meloen; R C Desrosiers; D P Burns; D P Bolognesi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

10.  Early appearance of antibodies to simian immunodeficiency virus in saliva and serum of infected macaques.

Authors:  T F Meiller; O Narayan; S V Joag; C D Overholser
Journal:  Clin Diagn Lab Immunol       Date:  1995-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.